AstraZeneca (AZN) has attractive valuation and 'best pipeline in sector' - BofA
Tweet Send to a Friend
BofA Securities analyst Sachin Jain reiterated a Buy rating and $88.00 price target on AstraZeneca (NASDAQ: AZN), saying it has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
